Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 764 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

for
Advanced Lung Non-Small Cell Carcinoma,
Location: Washington D.C. DC, Charlottesville VA, Media PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03191149

Phase2, Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

for
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Location: Washington D.C. DC, Falls Church VA, Silver Spring MD,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT05943535

Phase3, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Washington D.C. DC, Bethesda MD, Falls Church VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase3, Recruiting

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

for
Colorectal Cancer, Sarcopenia
Location: Washington D.C. DC, Newark DE, Wilmington DE,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 60+

Code: NCT03998202

Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Washington D.C. DC, Bethesda MD, Falls Church VA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

for
Parkinsons Disease (PD)
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: BlueRock Therapeutics

Sex: All

Age: 45 - 70+

Code: NCT06944522

Phase3, Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for
Acute Myeloid Leukemia
Location: Washington D.C. DC, Bethesda MD, Falls Church VA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase3, Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Washington D.C. DC, Bethesda MD, Frederick MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase2, Recruiting
New

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

for
Medulloblastoma, Medulloblastoma, Childhood,
Location: Washington D.C. DC
Sponsor: Sabine Mueller, MD, PhD

Sex: All

Age: 1 - 25

Code: NCT07346157

Phase1, Phase2, Recruiting

Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care

for
Asthma, Asthma in Children
Location: Washington D.C. DC
Sponsor: Kavita Parikh

Sex: All

Age: 4 - 12

Code: NCT05991115

Recruiting

Longitudinal Study of Urea Cycle Disorders

for
Brain Diseases, Metabolic, Inborn,
Location: Washington DC, Philadelphia PA, New York NY,
Sponsor: Andrea Gropman

Sex: All

Age: 0+

Code: NCT00237315

Recruiting

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

for
Medulloblastoma, Childhood,
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 1 - 30

Code: NCT06193759

Phase1, Recruiting

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Washington D.C. DC, Philadelphia PA, Pittsburgh PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 18

Code: NCT06247787

Phase1, Recruiting

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

for
Turner Syndrome
Location: Washington DC, Philadelphia PA, Chapel Hill NC,
Sponsor: University of Colorado, Denver

Sex: Female

Age: 0+

Code: NCT05052606

Recruiting

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

for
Hematologic Malignancy, AML, ALL, BPDCN, MDS,
Location: Washington DC, New York NY, Cincinnati OH, Ann Arbor MI,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All

Age: 1 - 21

Code: NCT05476770

Phase1, Recruiting

Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial

for
Sexually Transmitted Diseases
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 15 - 21

Code: NCT04372875

Recruiting

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

for
Sickle Cell Disease
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 2 - 25

Code: NCT06358638

Phase2, Recruiting

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

for
Sickle Cell Disease, Vaso-occlusive Pain Episode
Location: Washington D.C. DC
Sponsor: Suvankar Majumdar

Sex: All

Age: 4 - 21

Code: NCT06635902

Phase2, Recruiting

Targeted Pediatric High-Grade Glioma Therapy

for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Washington D.C. DC, Durham NC, Columbus OH,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 39

Code: NCT05839379

Recruiting

A Study to Assess Growth in Children With Idiopathic Short Stature

for
Idiopathic Short Stature
Location: Washington D.C. DC, Princeton NJ, The Bronx NY,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 2 - 16

Code: NCT06309979

Recruiting